DK3256107T3 - Farmaceutisk formulering af racecadotril - Google Patents
Farmaceutisk formulering af racecadotril Download PDFInfo
- Publication number
- DK3256107T3 DK3256107T3 DK15819831.7T DK15819831T DK3256107T3 DK 3256107 T3 DK3256107 T3 DK 3256107T3 DK 15819831 T DK15819831 T DK 15819831T DK 3256107 T3 DK3256107 T3 DK 3256107T3
- Authority
- DK
- Denmark
- Prior art keywords
- racecadotril
- pharmaceutical formulation
- formulation
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITTO20150086 | 2015-02-09 | ||
| PCT/EP2015/081187 WO2016128098A1 (en) | 2015-02-09 | 2015-12-23 | Pharmaceutical formulation of racecadotril |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3256107T3 true DK3256107T3 (da) | 2020-08-31 |
Family
ID=53002778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15819831.7T DK3256107T3 (da) | 2015-02-09 | 2015-12-23 | Farmaceutisk formulering af racecadotril |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US10188607B2 (da) |
| EP (1) | EP3256107B1 (da) |
| JP (1) | JP6851973B2 (da) |
| CN (1) | CN107438431B (da) |
| AU (1) | AU2015382526B2 (da) |
| BR (1) | BR112017016997A2 (da) |
| CA (1) | CA2975930A1 (da) |
| DK (1) | DK3256107T3 (da) |
| EA (1) | EA035038B1 (da) |
| ES (1) | ES2822992T3 (da) |
| GE (1) | GEP20197006B (da) |
| HU (1) | HUE051692T2 (da) |
| IL (1) | IL253788A0 (da) |
| LT (1) | LT3256107T (da) |
| PL (1) | PL3256107T3 (da) |
| PT (1) | PT3256107T (da) |
| SG (1) | SG11201706431SA (da) |
| WO (1) | WO2016128098A1 (da) |
| ZA (1) | ZA201705329B (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL2026905B1 (en) | 2020-11-16 | 2022-06-30 | Pharmamatch B V | Pharmaceutical granulate formulation and method for the preparation thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0015490D0 (en) * | 2000-06-23 | 2000-08-16 | Smithkline Beecham Lab | Novel formulations |
| FR2900823B1 (fr) * | 2006-05-15 | 2009-02-13 | Bioprojet Soc Civ Ile | Nouvelle forme d'administration du racecadotril. |
| WO2009015880A1 (en) * | 2007-07-31 | 2009-02-05 | Cargill, Incorporated | Direct compressible dextrose |
| CN102166197B (zh) * | 2011-04-25 | 2012-09-05 | 四川百利药业有限责任公司 | 消旋卡多曲颗粒及其生产工艺 |
| CN102327234B (zh) * | 2011-09-28 | 2017-04-12 | 海南康芝药业股份有限公司 | 一种消旋卡多曲干混悬剂 |
| CN104224724A (zh) * | 2013-06-08 | 2014-12-24 | 北京韩美药品有限公司 | 一种消旋卡多曲颗粒剂及其制备工艺 |
| ES2549127T1 (es) * | 2014-03-10 | 2015-10-23 | Galenicum Health S.L. | Composiciones farmacéuticas que comprenden un principio activo |
-
2015
- 2015-12-23 BR BR112017016997A patent/BR112017016997A2/pt active Search and Examination
- 2015-12-23 JP JP2017542893A patent/JP6851973B2/ja active Active
- 2015-12-23 ES ES15819831T patent/ES2822992T3/es active Active
- 2015-12-23 PT PT158198317T patent/PT3256107T/pt unknown
- 2015-12-23 CN CN201580075671.7A patent/CN107438431B/zh not_active Expired - Fee Related
- 2015-12-23 CA CA2975930A patent/CA2975930A1/en not_active Abandoned
- 2015-12-23 PL PL15819831.7T patent/PL3256107T3/pl unknown
- 2015-12-23 US US15/549,304 patent/US10188607B2/en not_active Expired - Fee Related
- 2015-12-23 EP EP15819831.7A patent/EP3256107B1/en active Active
- 2015-12-23 WO PCT/EP2015/081187 patent/WO2016128098A1/en active Application Filing
- 2015-12-23 AU AU2015382526A patent/AU2015382526B2/en not_active Ceased
- 2015-12-23 EA EA201791794A patent/EA035038B1/ru unknown
- 2015-12-23 GE GEAP201514562A patent/GEP20197006B/en unknown
- 2015-12-23 DK DK15819831.7T patent/DK3256107T3/da active
- 2015-12-23 SG SG11201706431SA patent/SG11201706431SA/en unknown
- 2015-12-23 LT LTEP15819831.7T patent/LT3256107T/lt unknown
- 2015-12-23 HU HUE15819831A patent/HUE051692T2/hu unknown
-
2017
- 2017-08-02 IL IL253788A patent/IL253788A0/en active IP Right Grant
- 2017-08-07 ZA ZA2017/05329A patent/ZA201705329B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN107438431B (zh) | 2020-12-15 |
| PT3256107T (pt) | 2020-09-23 |
| WO2016128098A1 (en) | 2016-08-18 |
| SG11201706431SA (en) | 2017-09-28 |
| PL3256107T3 (pl) | 2021-03-22 |
| HUE051692T2 (hu) | 2021-03-29 |
| AU2015382526A1 (en) | 2017-08-24 |
| JP2018505208A (ja) | 2018-02-22 |
| EP3256107A1 (en) | 2017-12-20 |
| LT3256107T (lt) | 2020-09-25 |
| US10188607B2 (en) | 2019-01-29 |
| EP3256107B1 (en) | 2020-08-12 |
| AU2015382526B2 (en) | 2020-09-10 |
| JP6851973B2 (ja) | 2021-03-31 |
| US20180028448A1 (en) | 2018-02-01 |
| GEP20197006B (en) | 2019-07-25 |
| BR112017016997A2 (pt) | 2018-04-10 |
| CA2975930A1 (en) | 2016-08-18 |
| ES2822992T3 (es) | 2021-05-05 |
| IL253788A0 (en) | 2017-09-28 |
| ZA201705329B (en) | 2019-06-26 |
| EA201791794A1 (ru) | 2017-12-29 |
| EA035038B1 (ru) | 2020-04-21 |
| CN107438431A (zh) | 2017-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3529248T3 (da) | Farmaceutiske sammensætninger | |
| DK3302565T3 (da) | Faste doseringsformer af palbociclib | |
| DK3244948T3 (da) | Bestemmelse af medikamentdosis | |
| DK3509581T3 (da) | Formuleringer af (r)-2-amino-3-phenylpropylcarbamat | |
| DK3116491T3 (da) | Farmaceutiske sammensætninger af terapeutisk aktive forbindelser | |
| DK3368014T3 (da) | Nye formuleringer af cannabinoider | |
| DK3157508T3 (da) | Fast oral doseringsform af lipofile forbindelser | |
| DK3185853T3 (da) | Inhalerbare pulverformuleringer af alginatoligomerer | |
| MA50541A (fr) | Formulations pharmaceutiques | |
| DK3378482T3 (da) | Formulering til administration af antitumorlægemiddel | |
| DK3237045T3 (da) | Indretning til indgivelse af lægemidler | |
| ES2972229T3 (es) | Composiciones farmacéuticas de apremilast | |
| DK3529240T3 (da) | Farmaceutiske forbindelser | |
| MA42303A (fr) | Formulations pharmaceutiques | |
| BR112017008125A2 (pt) | redução da viscosidade de formulações farmacêuticas | |
| DK3634377T3 (da) | Farmaceutisk formulering | |
| DK3368044T3 (da) | Behandling af hepatisk steatose-relateret oligo-ovulation | |
| MA43705A (fr) | Formulation pharmaceutique | |
| DK3297619T3 (da) | Terapeutiske anvendelser af L-4-chlorkynurenin | |
| DK3310331T3 (da) | Injicerbare farmaceutiske formuleringer af lefamulin | |
| DK3191085T3 (da) | Misbrugsresistente farmaceutiske sammensætninger | |
| FR3039396B1 (fr) | Base de formulation cosmetique concentree | |
| DK3400017T3 (da) | Kontinuerlig kompleksering af aktive farmaceutiske ingredienser | |
| DK3280447T3 (da) | Farmaceutiske formuleringer | |
| DK3678644T3 (da) | Formuleringer af copanlisib |